Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ACYCLOVIR | 200MG | TABLET | Anticipated shortage | 2025-04-23 | 2025-04-23 | 255406 |
| MYLAN-ACYCLOVIR | 200MG | TABLET | Resolved | 2023-02-01 | 2023-03-20 | 182969 |
| MYLAN-ACYCLOVIR | 400MG | TABLET | Resolved | 2024-12-03 | 2025-01-21 | 244619 |
| MYLAN-ALENDRONATE | 70MG | TABLET | Resolved | 2017-04-07 | 2018-07-05 | 5984 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-10-30 | 2024-03-25 | 208613 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2017-10-26 | 2019-01-22 | 27110 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2018-07-25 | 2019-02-16 | 56507 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149970 |
| MYLAN-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2021-11-26 | 2022-03-23 | 149967 |
| MYLAN-ALMOTRIPTAN | 6.25MG | TABLET | Resolved | 2023-12-13 | 2024-03-25 | 213129 |
| MYLAN-ALPRAZOLAM | 2MG | TABLET | Resolved | 2018-04-03 | 2018-07-05 | 44786 |
| MYLAN-ALPRAZOLAM | 1MG | TABLET | Resolved | 2017-04-04 | 2017-08-24 | 5326 |
| MYLAN-ALPRAZOLAM | 0.25MG | TABLET | Resolved | 2017-04-07 | 2017-12-02 | 5966 |
| MYLAN-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2017-04-13 | 2018-07-05 | 6973 |
| MYLAN-AMIODARONE | 200MG | TABLET | Avoided shortage | 2017-03-23 | 2017-05-04 | 4090 |
| MYLAN-AMIODARONE | 200MG | TABLET | Avoided shortage | 2017-03-31 | 2017-05-04 | 5046 |
| MYLAN-AMIODARONE | 200MG | TABLET | Resolved | 2017-04-04 | 2018-07-03 | 5335 |
| MYLAN-AMLODIPINE | 5.0MG | TABLET | Resolved | 2017-11-08 | 2018-02-10 | 28616 |
| MYLAN-AMLODIPINE | 10.0MG | TABLET | Resolved | 2017-11-03 | 2018-02-10 | 28029 |
| MYLAN-AMLODIPINE/ATORVASTATIN | 80MG 5MG | TABLET | Anticipated shortage | 2025-04-23 | 2025-04-28 | 255415 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |